about
Experimental treatment of antipsychotic-induced movement disordersPharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genesTardive dyskinesia in relation to estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data.Vitamin E in the treatment of tardive dyskinesia.Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations.Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trialNBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanismsAntipsychotic drug-induced movement disorders.Pharmacotherapy of first-episode psychosis.Atypical Antipsychotic Use in the Treatment of Psychosis in Primary CareBasic immunological aspects of botulinum toxin therapy.Drug-induced movement disorders in children and adolescents.Tardive dyskinesia: treatment with aripiprazole.Treatment of neurolept-induced tardive dyskinesiaTreatment outcomes of patients with tardive dyskinesia and chronic schizophrenia.Atypical antipsychotic-induced metabolic disturbances in the elderly.Treating psychosis in movement disorder patients: a review.Comparing the risk of tardive dyskinesia in older adults with first-generation and second-generation antipsychotics: a systematic review and meta-analysis.A case of tardive dyskinesia in the last weeks of life.Tardive Dyskinesia Associated with BupropionTardive dyskinesia in a patient treated with quetiapine.Antipsychotic use in Australia: the patients' perspective.Support for association of HSPG2 with tardive dyskinesia in Caucasian populations.Reversal of haloperidol-induced orofacial dyskinesia by quercetin, a bioflavonoid.Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory study.Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients.Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.Effects of vitamin E supplementation on plasma membrane permeabilization and fluidization induced by chlorpromazine in the rat brain.Ilex paraguariensis has antioxidant potential and attenuates haloperidol-induced orofacial dyskinesia and memory dysfunction in rats.The current status of tardive dyskinesia
P2860
Q26740354-C59087BB-32DE-4EB9-AB01-8663AC491C25Q28088705-AF405741-0288-41AB-9CF5-56237E85AF5BQ30747608-E1CBA54F-37B3-48DD-9B43-5027259E0DF9Q33779870-3B195E2B-E022-4EFB-A676-6A00453DCD26Q34145800-599E6030-BC2B-495D-89A8-84DA75743BD0Q34480263-51A1B628-DBE6-404E-B6BD-E35EC906A6CCQ34492934-E381FB9D-E301-4CC9-A012-1C31BFB2652EQ35044374-B4FEF423-C43A-45B3-A264-2EEFAFE123A7Q35105771-0A132D78-008D-4165-8A62-4F3CA3F90B37Q35124708-B9C35F28-0BFF-4B5F-A492-16217C1E47AEQ35665593-C49B0CF9-7239-467E-BDB0-2303A7FE342BQ35693983-F9DE4239-97CF-41EB-871B-AE58CBADAA41Q36040766-23609F00-366C-48A3-95A8-636FE60976A6Q36599203-D5F96733-5819-4650-A814-0F638C02639BQ37198420-10D38F69-9324-42C3-A1BD-65DC21669BA3Q37302639-AF872627-087D-4328-84AC-08503DF969E6Q38183274-14740470-C897-438A-ACA0-A8BEF726ACA0Q38213306-13596D8F-B53C-4AB6-9E71-289D526DB73FQ38672583-D364699D-F14C-49F6-B847-59640F990952Q39187554-80ACF5A8-4118-402E-9E5E-82A85A6999FEQ42352471-3BC70C73-900D-4A66-9D07-64BE1A12371BQ43293457-B323881C-B35C-4DEC-8B61-BCD5C413E716Q44133345-A253C64D-C699-4A1E-B1EC-6AD02D0EC0E8Q44208517-4625CAB4-0867-466E-A287-B31298265536Q44386044-D84C01CB-DB0E-4015-BD6D-E0EE59A56D2EQ45007058-1F508BDC-FAE1-4084-8E7F-38B87B8DF333Q46111815-A3A6AEB7-8637-46A2-AB0A-3521B6DC765BQ46422249-1F315434-97C0-4109-8CCB-960C1DAB5AACQ46798703-93EF54B2-6805-4F4C-9FA9-95B37FE7FB94Q46925676-0F2F80E4-126F-4F40-B42A-A6DF4B38CFCDQ57725386-B6424B7B-D37C-4EFC-A882-C481FC3DA5B4
P2860
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Treatment of tardive dyskinesia.
@ast
Treatment of tardive dyskinesia.
@en
Treatment of tardive dyskinesia.
@nl
type
label
Treatment of tardive dyskinesia.
@ast
Treatment of tardive dyskinesia.
@en
Treatment of tardive dyskinesia.
@nl
prefLabel
Treatment of tardive dyskinesia.
@ast
Treatment of tardive dyskinesia.
@en
Treatment of tardive dyskinesia.
@nl
P2093
P356
P1476
Treatment of tardive dyskinesia.
@en
P2093
P304
P356
10.1093/SCHBUL/23.4.583
P407
P577
1997-01-01T00:00:00Z